N-Propyltryptamine

N-Propyltryptamine
Clinical data
Other namesNPT; N-n-Propyltryptamine
Drug classSerotonin receptor modulator
ATC code
  • None
Identifiers
  • N-[2-(1H-indol-3-yl)ethyl]propan-1-amine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC13H18N2
Molar mass202.301 g·mol−1
3D model (JSmol)
  • CCCNCCC1=CNC2=CC=CC=C21
  • InChI=1S/C13H18N2/c1-2-8-14-9-7-11-10-15-13-6-4-3-5-12(11)13/h3-6,10,14-15H,2,7-9H2,1H3
  • Key:KBFBIAGUZWNRFI-UHFFFAOYSA-N

N-Propyltryptamine (NPT) is a serotonin receptor modulator of the tryptamine family related to N-methyltryptamine (NMT).[1][2][3] According to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), NPT is not known to have been tested in humans.[1] It acts as a serotonin receptor agonist in the rat uterus and stomach strip, with slightly lower potency than dimethyltryptamine (DMT).[4][3] However, in contrast to DMT and NMT, NPT did not cause central effects in dogs.[2][5] It is said to be less toxic than dipropyltryptamine (DPT) in rodents.[1] The chemical synthesis of NPT has been described.[1][6] NPT was first described in the scientific literature by Speeter and Anthony by 1954.[2][4][3][5] Subsequently, the drug was described by Shulgin in TiHKAL in 1997.[1]

See also

References

  1. ^ a b c d e Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252. "The normal-propylamine NPT has been made by the oxalylamide route, with the amide having with a mp 179–181 °C (75%) from benzene and NPT hydrochloride mp 186–187 °C (33%) from MeOH/benzene. An attempt to make NPT by the alkyl halide procedure failed. Using these same ratios of reactants, there was the formation of a sizable quantity of DPT with appreciable unreacted tryptamine presence (T:NPT:DPT/1:5:4). A recycling under the same conditions gave T:NPT:DPT/0:3:7) and a third cycle gave only DPT, but with a loss of almost 90% of the material presumably to quaternary salt formation. Interestingly NPT is less toxic than DPT in experimental mice, but has not been assayed yet in man."
  2. ^ a b c Shulgin AT (1976). "Psychotomimetic Agents". In Gordon M (ed.). Psychopharmacological Agents: Use, Misuse and Abuse. Medicinal Chemistry: A Series of Monographs. Vol. 4. Academic Press. pp. 59–146. doi:10.1016/b978-0-12-290559-9.50011-9. ISBN 978-0-12-290559-9. Little is known of the monosubstituted tryptamines. N-Methyltryptamine has been mentioned as a minor component in Anadenanthera spp. It has also been identified in the bark of Virola theiodora (Cassidy et al., 1969), a plant that is one of the principal sources of the carbo-line psychotomimetics. In comparison with dimethyltryptamine, mono-methyltryptamine produces less central stimulation in the dog, and the monopropyl homolog [(XXIII), R = n-C3H7] is without activity (Conner, 1954). The n-hexyl homolog [(XXIII), R = n-C6H13] has been found inactive in a limited number of subjects (Szara, 1967). The mono-tert-butyl derivative [(XXIII), R = t-C4H9) has the reputation of oral activity (see above discussion concerning anonymous street knowledge), but dosage details are not known.
  3. ^ a b c Barlow RB, Khan I (March 1959). "Actions of some analogues of tryptamine on the isolated rat uterus and on the isolated rat fundus strip preparations". British Journal of Pharmacology and Chemotherapy. 14 (1): 99–107. doi:10.1111/j.1476-5381.1959.tb00934.x. PMC 1481812. PMID 13651585.
  4. ^ a b Vane JR (March 1959). "The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation". British Journal of Pharmacology and Chemotherapy. 14 (1): 87–98. doi:10.1111/j.1476-5381.1959.tb00933.x. PMC 1481817. PMID 13651584.
  5. ^ a b Speeter ME, Anthony WC (1954). "The Action of Oxalyl Chloride on Indoles: A New Approach to Tryptamines". Journal of the American Chemical Society. 76 (23): 6208–6210. Bibcode:1954JAChS..76R6208S. doi:10.1021/ja01652a113. ISSN 0002-7863. (5) Studies by Dr. Nolen Connor of our Laboratories indicate the hydroxyl group is not essential for activity on the central nervous system as 3-(2-dimethylaminoethyl) indole [(DMT)] has grossly the same action in the dog as bufotenine [(5-HO-DMT)]. In contrast, 3-(2-methylaminoethyl)-indole [(NMT)] has slight activity while 3-(2-n-propylaminoethyl)-indole [(NPT)] produced no apparent symptoms.
  6. ^ Jensen N (2004). Tryptamines as Ligands and Modulators of the Serotonin 5-HT2A Receptor and the Isolation of Aeruginascin from the Hallucinogenic Mushroom Inocybe aeruginascens (PhD thesis). Georg-August-Universität zu Göttingen.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.